Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala at the University of Eastern Finland, with Professor Seppo Vainio from the University of Oulu as its deputy director. Other partners in the Flagship include the University of Helsinki, Aalto University and the Finnish Red Cross Blood Service.
Academy of Finland supplemented its flagship programme — University of Oulu included in the GeneCellNano project
Four new competence clusters have been added to the Academy of Finland’s Flagship Programme. The University of Oulu is involved in the GeneCellNano Flagship, i.e. Gene, Cell and Nano Therapy Competence Cluster for the Treatment of Chronic Diseases.
The Falling Walls Science Breakthroughs of the Year presents Seppo Vainio as one of the finalists;
COVID-19 has had significant impact on research conducted at the Faculty of Biochemistry and Molecular Medicine, University
Professor Caglar Elbuken arrived in Oulu last winter from Ankara, Turkey, to take on a new career challenge. Namely, the founding of two research groups for the University of Oulu and the VTT Technical Research Center of Finland, respectively.
The University of Oulu collects information worldwide on the effects of the coronavirus crisis on people's everyday life. Experiencing the Pandemic project material will be used in a variety of disciplines, including in dealing with potential new crises.
The Sigrid Jusélius Foundation has 18.3.2020 granted 1-3 year grants for following senior researchers and young group leaders, at FBMM: Lauri Eklund, Peppi Karppinen, Lari Lehtiö, Alexander Kasta
The Foundation for the Finnish Cancer Institute has appointed Dr. Valerio Izzi to the post of K. Albin Johansson Cancer Research Fellow.
The MEDigi project coordinated by the University of Oulu harmonises basic education in medical fields in Finland and develops it in terms of digitalisation. The latter is visible in both teaching content and methods.
Jane and Aatos Erkko Foundation has granted significant funding to the researchers of the University of Oulu. Foundation has granted 1,5 million euro funding for Professors Johanna Myllyharju and Peppi Karppinen of the University of Oulu. The grant was awarded for hypoxia-related research (Key enzyme regulators of the hypoxia response, collagen synthesis and epigenetic pathways as therapeutic targets) for five years.
The leukemic matrisome interface as a source of markers and targets for acute myeloid leukemia - ELMI is a research consortium led by Prof.
This year’s Nobel Prize in Medicine will be awarded on 10 December to three researchers studying hypoxia – low oxygen concentrations. The Faculty of Biochemistry and Molecular Medicine of the University of Oulu has made its significant contribution to the subject.
Digital health technology is one of the most important research themes at the University of Oulu. The DigiHealth project also takes researchers to the corridors of Oulu University Hospital.
The Equality and Diversity Committee of the University of Oulu has given the 2019 Equality and Diversity Award to former doctoral researcher Vasiliki Mylonopoulou and Management Assistant Pia Askonen.
Professor Gong-Hong Wei’s research group awarded for their work into the mechanisms of aggressive prostate cancer
The Minerva Foundation’s Medix prize in biomedical basic research has this year been awarded to a research group headed by Professor of Biochemistry and Molecular Medicine Gong-Hong Wei at the University of Oulu.
Research related to fibrotic diseases is one of the profiling themes of research conducted at the University of Oulu.
Telling about one's expertise is talked about a lot, but what means could be offered to the students' to help them recognise their skills? The students' at the Faculty of Biochemistry and Molecular Medicine came up with a way.
The biyearly Publiikki took place 23.5.
Mikko Hynönen was nominated the Teacher of the Year 2019. The Faculty nominates one young teacher (a Ph.D.
Finnish researchers at the University of Eastern Finland and the University of Oulu have discovered of a new type of gene mutation that reduces fear and anxiety, and increases social interaction. The researchers employed gene manipulation technology to remove the P4h-tm gene from the mouse genome and found an unexpected change in mouse behaviour. P4h-tm knockout mice showed striking courage and a lack of learned helplessness compared to congenic wild-type mice with a functional P4h-tm gene. The results were published in Neuropharmacology.
Researchers found a new mechanism by which cells can sense oxygen – new opportunities will open for the development of cancer drugs
Researchers from the University of Oulu and Harvard University have found a previously unknown mechanism by which cells in the body sense oxygen. Lack of oxygen had a direct influence on the functioning of genes, and prevented cell differentiation. This observation will open up new opportunities for the development of cancer drugs. The study was published in the prestigious Science journal.
Professor Seppo Vainio, as a partner in two H2020 FET Open projects, GLADIATOR and MindGAP, has received significant project funding.